Shamburg News · 8-K filed Nov 10, 2026, 4:27 PM EST

Biomea Fusion Reports Third Quarter 2026 Financial Results

BMEA · Biomea Fusion, Inc.

  • Earnings
  • Materiality: high

Biomea Fusion, Inc. reported financial results for the quarter ended September 30, 2026, with a net loss attributable to common stockholders of $6.2 million, compared with $16.4 million for the same period in 2025. As of September 30, 2026, the company had cash, cash equivalents and restricted cash of $26.8 million, and it projected cash runway into the second quarter of 2027. The release also covered clinical updates for icovamenib and the Phase I results for BMF-650.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001193125-26-455557.

Written from the filing by Shamburg Markets. Figures are as reported by the company.